Sign in
HALB Stock Price, Chart, Stats & News
Halberd Corporation
Save
Halberd Corporation (HALB) does not currently pay a dividend.
386,906
Market cap
–
Current P/E
–
Forward P/E
HALB chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.
Similar securities
Based on sector and market capitalization
Report issue